Abstract
Popular ready-to-use β2-agonist preparations (in particular, salbutamol) available in the form of dry powders for inhalation are reviewed. Examples of the preparation of drug powders for inhalation are given and the specific features of physicochemical, structural, mechanical, and technological properties of the products are considered. The role of auxiliary substances in such preparations is discussed, and the use of a new auxiliary substance (sodium benzoate) instead of lactose is described.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
D. Bellamy, Why is salbutamol such a popular drug? 12, 33–35 (1991).
M. Johnson, Lung. Suppl., 2, 115–119 (1990).
A. E. Tattersfield, Br. Med. Bull., 48, 190–204 (1992).
A. I. Sinopal'nikov and I. L. Klyachkina, Ros. Med. Zh., 10(5), 34–41 (1997).
I. D. Apul'tsina, A. S. Sokolov, T. L. Pashkova, et al., Pulmonologiya, 9(2), 59–65 (1999).
S. L. Babak and A. G. Chuchalin, Ros. Med. Zh., 6(17), 27–36 (1998).
European Pharmacopoeia. Preparations for Inhalation. European Pharmacopoeia Supplement., 2001:2.9.18.
S. N. Avdeev, Ros. Med. Zh., 10(5), 13–19 (2002).
H. Chrystyn, Respir Med., 91, 17–19 (1997).
UK Patent No. 2107715; Chem. Abstr., 95, 1234 (1983).
U. B. Patel, J. Pharm. Pharmacol, 37, 108–111 (1985).
FRG Patent No. 2943658; Chem. Abstr., 90, 9861 (1980).
M. Vidgren, A. Karkjainen, P. Karjalainen, et al., Pulmonologiya, 1(4), 37–43 (1991).
J. Karpel, Adv. Therapy, 17, 283–287 (2000).
“Workshop on Medical Aerosol,” Medical Way, 1(9), 158–159 (1984).
US Patent No. 6053960 (2003).
UK Patent No. 2008725; Chem. Abstr., 92, 13241 (1981).
UK Patent No. 2105189; Chem. Abstr., 95, 24341 (1983).
US Patent No. 5478578; Chem. Abstr., 122, 2138 (1995).
European Patent No. 0239798; Chem. Abstr., 115, 19364 (1987).
UK Patent No. 4103174; Chem. Abstr., 134, 17241 (2001).
US Patent No. 5972388; Chem. Abstr., 130, 24390 (1999).
D. Kenyon, T. Yang, and A. Kaufman, in: Respiratory Drug Delivery VII, R. N. Dalby, P. R. Byron, and S. J Farr (eds.), Serentec Press (2000), Vol. 1, pp. 495–498.
D. Kenyon, Am. J. Respir. Crit. Care. Med., 163, A440 (2001).
T. Yang and D. Kenyon, in: Respiratory Drug Delivery VII, R. N. Dalby, P. R. Byron, and S. J Farr (eds.), Serentec Press (2000), Vol. 2, pp. 503–506.
T. T. Yang, S. Li, B. Wyka, and D. Kenyon, J. Aerosol Med., 14, 487–494 (2001).
B. Fan, T. Yang, and D. Kenyon, Am. J. Respir. Crit. Care. Med., 161, A456 (2000).
European Patent No. 0260241; Chem. Abstr., 117, 14213 (1988).
International Patent No. 87/05803; Chem. Abstr., 115, 9613 (1987).
International Patent No. 87/07502; Chem. Abstr., 115, 742513 (1987).
International Patent No. 88/011657; Chem. Abstr., 117, 3295 (1988).
European Patent No. 0145240; Chem. Abstr., 97, 47423 (1984).
A. V. Emel'yanov and T. E. Elizarova, Pulmonologiya, 13(1), 31–39 (2003).
S. N. Avdeev, Ros. Med. Zh., 9(21), 75–81 (2001).
L. Knight and J. Fletcher, Infect. Diseas., 123, 371–377 (1971).
C. Frank and M. D. Voest, Ann. Allerg., 43(4), 205–210 (1979).
RF Patent No. 2054932 (1992); Byull. Izobret., No. 6 (1996).
Author information
Authors and Affiliations
Additional information
__________
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 39, No. 6, pp. 44 – 47, June, 2005.
Rights and permissions
About this article
Cite this article
Garkavaya, T.N., Petrugova, N.P., Skachilova, S.Y. et al. Beta-2 Lgonists for Inhalation in the Form of Dry Powders. Pharm Chem J 39, 329–332 (2005). https://doi.org/10.1007/s11094-005-0146-4
Received:
Issue Date:
DOI: https://doi.org/10.1007/s11094-005-0146-4